在不可切除的肝细胞癌的转化疗法中,基于伦瓦替尼的治疗方案:系统性审查和元分析

Saixin Li1,2, Zeyu Zhang3, Zheng Wang1,2

  • 1Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, P.R. China.

Oncology letters
|April 25, 2024
PubMed
概括

基于伦瓦替尼的疗法对不可切除的肝细胞癌 (uHCC) 转化有前途. 像伦瓦提尼布加免疫检查点抑制剂 (ICI) 等组合,带或不带区域治疗 (LRT),提供有效的治疗,可接受的安全性.

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K